(in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 | 29 Mar 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | $237 | |||
Short term investments | $47 | |||
Net receivables | $172 | $224 | ||
Inventory | ||||
Total current assets | $458 | $508 | ||
Long term investments | $887 | |||
Property, plant & equipment | $46 | $53 | ||
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $1323 | $1395 | ||
Current liabilities | ||||
Accounts payable | $6 | $17 | ||
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $321 | $356 | ||
Long term debt | $194 | $194 | ||
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $581 | $619 | ||
Shareholders' equity | ||||
Retained earnings | -$2200 | -$2158 | ||
Other shareholder equity | -$15 | -$14 | ||
Total shareholder equity | $776 |
(in millions $) | 31 Jan 2025 | 31 Jan 2024 | 28 Mar 2023 | 31 Dec 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $237 | $426 | $214 | |
Short term investments | $47 | $182 | $334 | |
Net receivables | $224 | $135 | $217 | |
Inventory | ||||
Total current assets | $508 | $743 | $1006 | |
Long term investments | $887 | $936 | $30 | |
Property, plant & equipment | $53 | $69 | $48 | |
Goodwill & intangible assets | ||||
Total noncurrent assets | $1812 | |||
Total investments | ||||
Total assets | $1395 | $1679 | $2818 | |
Current liabilities | ||||
Accounts payable | $17 | $24 | $20 | |
Deferred revenue | $225 | |||
Short long term debt | $367 | |||
Total current liabilities | $356 | $729 | $429 | |
Long term debt | $194 | $720 | ||
Total noncurrent liabilities | $885 | |||
Total debt | ||||
Total liabilities | $619 | $822 | $1314 | |
Shareholders' equity | ||||
Retained earnings | -$2158 | -$2028 | -$1306 | |
Other shareholder equity | -$14 | -$18 | -$13 | |
Total shareholder equity | $776 | $857 | $1556 |
(in millions $) | 30 Jul 2025 | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 |
---|---|---|---|---|
Revenue | ||||
Total revenue | ||||
Cost of revenue | ||||
Gross Profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | ||||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | ||||
Interest expense | ||||
Net income | ||||
Net income | ||||
Income (for common shares) |
(in millions $) | 29 Mar 2024 | 31 Jan 2023 | 28 Mar 2022 | 27 Feb 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $853 | $893 | ||
Cost of revenue | $250 | |||
Gross Profit | $520 | $643 | ||
Operating activities | ||||
Research & development | $215 | |||
Selling, general & administrative | $342 | |||
Total operating expenses | $558 | $989 | ||
Operating income | -$96 | |||
Income from continuing operations | ||||
EBIT | -$96 | |||
Income tax expense | $24 | -$9 | ||
Interest expense | $19 | -$15 | ||
Net income | ||||
Net income | -$130 | -$1104 | ||
Income (for common shares) | -$1104 |
(in millions $) | 1 Jul 2024 | 29 Mar 2024 | 30 Dec 2023 | 1 Oct 2023 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$26 | $46 | $112 | $76 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $1 | -$165 | -$211 | $2 |
Effect of exchange rate | ||||
Change in cash and equivalents | -$40 | -$122 | -$87 | $121 |
(in millions $) | 29 Mar 2024 | 28 Mar 2023 | 27 Feb 2022 | 27 Feb 2021 |
---|---|---|---|---|
Net income | $12 | -$1104 | ||
Operating activities | ||||
Depreciation | $176 | $198 | ||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | -$28 | $82 | ||
Investing activities | ||||
Capital expenditures | -$8 | -$8 | ||
Investments | $222 | $3 | ||
Total cash flows from investing | $46 | $176 | $207 | -$65 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | -$246 | |||
Total cash flows from financing | -$165 | $6 | $10 | -$227 |
Effect of exchange rate | -$3 | -$1 | $2 | |
Change in cash and equivalents | -$122 | -$84 | $188 | -$208 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |